Duration of Peripheral Nerve Blocks in Opioid Tolerant Individuals - A Volunteer Blinded Matched Case-control Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Background: Peripheral nerve blocks effectively alleviate postoperative pain. Animal studies and human research indicate that opioid tolerance results in reduced effectiveness of local analgesics. This applies to both central nerve blockade and infiltration anaesthesia. The impact on peripheral nerve block in humans has not been evaluated. The aim of the study is to assess the onset time and duration of a radial nerve block in opioid tolerant individuals compared to opioid naive individuals. We hypothesise that peripheral nerve blocks cause shorter sensory and motor block in opioid-tolerant compared to opioid-naive counterparts.

Methods: Twenty opioid-tolerant individuals will be matched by sex and age with opioid-naïve counterparts. Participants will undergo an ultrasound-guided radial nerve block. The onset time and duration of motor and sensory blockade will be tested and measured. The primary outcome is difference in duration of sensory nerve blockade between the two groups. The secondary outcomes include the onset time of sensory blockade, onset time of motor blockade, and difference in duration of motor nerve blockade. Perspectives: The data from this study will provide evidence for the duration of peripheral nerve block in opioid tolerant individuals and support if a specific postoperative protocol for opioid tolerant individuals is needed or it should be of special attention.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 84
Healthy Volunteers: t
View:

• Age \> 18 years old

• ASA 1-3

• Chronic pain, defined as persisting pain for more than three months

• Daily use of more than 60 mg of morphine equivalent in more than 7 days

• Legally competent and able to give informed consent

• Age \> 18 years old

• ASA 1-3

• No use of opioids within 30 days prior to participation

• Legally competent and able to give informed consent

Locations
Other Locations
Denmark
Silkeborg Regional Hospital
RECRUITING
Silkeborg
Contact Information
Primary
Mikkel SH Jensen, MD
mikpes@rm.dk
20333104
Backup
Charlotte Runge, MD
charlotte.runge@aarhus.rm.dk
78416681
Time Frame
Start Date: 2024-06-17
Estimated Completion Date: 2025-05-01
Participants
Target number of participants: 40
Treatments
Experimental: Opioid tolerant
Daily use of opioid of 60 mg or more
Experimental: Opioid naive
No use of opioids within the last 30 days
Related Therapeutic Areas
Sponsors
Leads: Charlotte Runge

This content was sourced from clinicaltrials.gov